Discover the projected growth and lucrative markets in the global pharmaceutical industry, with a focus on oncology and other ...
Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global ...
The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...
The Motley Fool on MSN16d
3 Magnificent Growth Stocks to Buy in MarchVertex Pharmaceuticals boasts multiple growth avenues. Amgen could tap into more growth opportunities by entering the GLP-1 market. Prosper Junior Bakiny (Eli Lilly): What's considered excellent ...
Analysts have set 12-month price targets for Eton Pharmaceuticals, revealing an average target of $24.4, a high estimate of $33.00, and a low estimate of $17.00. Marking an increase of 22.0%, the ...
Analysts have recently evaluated Ultragenyx Pharmaceutical and provided 12-month price targets. The average target is $104.8, ...
5d
The Print on MSNHow reciprocal Trump tariffs may impact Indian pharma, and become a bitter pill for the USSpooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...
The global pharmaceuticals market is estimated to reach $1.21 trillion in 2025, according to Statista data. Overall, Statista predicted the worldwide pharma industry market revenue will increase 4 ...
LONDON, March 20 (Reuters) - The pharmaceutical industry on Thursday blasted the ... is forcing them to pay between a quarter and a third of revenues from drug sales in the country back to the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results